A Phase II Trial Investigating Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2016
Price : $35 *
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide; Etoposide
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 21 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 01 Dec 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 May 2013 Planned initiation date changed from 1 Dec 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.